Little Green Pharma Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.36%

Little Green Pharma Ltd (LGP) has an Asset Resilience Ratio of 2.36% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$2.30 Million

≈ $1.63 Million USD Cash + Short-term Investments

Total Assets

AU$97.60 Million

≈ $69.06 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Little Green Pharma Ltd's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Little Green Pharma Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Little Green Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see LGP market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$2.30 Million	2.36%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$2.30 Million	2.36%

Asset Resilience Insights

Limited Liquidity: Little Green Pharma Ltd maintains only 2.36% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Little Green Pharma Ltd Industry Peers by Asset Resilience Ratio

Compare Little Green Pharma Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	15.57%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%

Annual Asset Resilience Ratio for Little Green Pharma Ltd (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Little Green Pharma Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	2.47%	AU$2.38 Million ≈ $1.68 Million	AU$96.12 Million ≈ $68.01 Million	-3.29pp
2024-06-30	5.76%	AU$4.97 Million ≈ $3.52 Million	AU$86.38 Million ≈ $61.12 Million	-6.82pp
2023-06-30	12.57%	AU$12.40 Million ≈ $8.77 Million	AU$98.62 Million ≈ $69.78 Million	-8.36pp
2022-06-30	20.94%	AU$20.09 Million ≈ $14.21 Million	AU$95.95 Million ≈ $67.89 Million	-15.35pp
2021-06-30	36.28%	AU$40.27 Million ≈ $28.49 Million	AU$110.99 Million ≈ $78.53 Million	+10.23pp
2020-06-30	26.05%	AU$4.27 Million ≈ $3.02 Million	AU$16.40 Million ≈ $11.61 Million	+22.77pp
2019-06-30	3.28%	AU$510.29K ≈ $361.06K	AU$15.57 Million ≈ $11.01 Million	-33.38pp
2018-06-30	36.65%	AU$1.47 Million ≈ $1.04 Million	AU$4.02 Million ≈ $2.85 Million	--

pp = percentage points

About Little Green Pharma Ltd

AU:LGP Australia Drug Manufacturers - Specialty & Generic

Market Cap

$16.01 Million

AU$22.63 Million AUD

Market Cap Rank

#25743 Global

#1133 in Australia

Share Price

AU$0.07

Change (1 day)

-1.33%

52-Week Range

AU$0.06 - AU$0.14

All Time High

AU$0.94